FEB 24, 2018 12:50 PM PST

Tumors Eradicated by Immune-stimulating Agents

WRITTEN BY: Carmen Leitch

With mice as a model, researchers at Stanford discovered that by injecting two molecules that stimulate the immune system, solid tumors and any trace of cancer could be eliminated. This T cell activating therapy could work for many types of cancer. Because only small amounts are needed in a targeted approach, the researchers believe this could be an affordable treatment that doesn’t cause as many side effects as other therapeutics.

A scanning electron micrograph of a healthy human T cell. / Credit: NIH

“When we use these two agents together, we see the elimination of tumors all over the body,” noted Ronald Levy, MD, professor of oncology. He was senior author of a report in Science Translational Medicine summarizing the findings. “This approach bypasses the need to identify tumor-specific immune targets and doesn’t require wholesale activation of the immune system or customization of a patient’s immune cells.”

One drug is already approved for human use, and the other has undergone testing for human patients in a few unrelated clinical trials. This January, a new clinical trial was launched to assess this treatment in lymphoma patients.

There has been considerable interest in developing drugs that use the immune system to fight cancer. Some approaches rely on bodywide stimulation; others remove a patient’s immune cells and genetically alter them to combat cancer before reinjecting them. While there have been other attempts as well, none have been entirely successful. Some are very expensive or laborious; others cause serious side effects. 

“All of these immunotherapy advances are changing medical practice,” Levy said. “Our approach uses a one-time application of very small amounts of two agents to stimulate the immune cells only within the tumor itself. In the mice, we saw amazing, bodywide effects, including the elimination of tumors all over the animal.”

Typically, cells of the immune system that should recognize foreign invaders, T cells, will attack cancer cells at first, but as cancerous tumors grow, they are often able to suppress T cell activity.

Levy’s team aimed to stimulate T cells that target cancer by exposing them to minuscule amounts of two agents at the site of tumors. One is a short snippet of DNA called an oligonucleotide; it boosts the expression of a T cell receptor. The other molecule is an antibody that binds to that receptor. Together, the antibody and receptor team up to activate the T cells. Only T cells that have gotten into the tumor are activated since the agents are applied to the tumor directly. Those T cells can recognize a specific cancer, and some leave the site of the tumor. They then migrate throughout the body and destroy other, similar tumors.

This was a remarkably effective approach that worked in transplanted lymphoma tumors, with both the original injected tumor getting destroyed as well as a second, uninjected tumor. The therapy also worked on genetically engineered mice that develop breast cancer. In the cases of cancers that grew back after the first treatment, a second treatment removed it again.

After testing mice that had been transplanted to receive lymphoma tumors and colon cancer, the treatment eliminated the lymphoma tumors, but not the colon cancer.

“This is a very targeted approach,” Levy explained. “Only the tumor that shares the protein targets displayed by the treated site is affected. We’re attacking specific targets without having to identify exactly what proteins the T cells are recognizing.”

If the current trial, which will have around fifteen lymphoma patients, is successful, the researchers want to find out if it works with other kinds of cancer.

“I don’t think there’s a limit to the type of tumor we could potentially treat, as long as it has been infiltrated by the immune system,” Levy said.


Sources: Stanford University, Science Translational Medicine

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
APR 13, 2020
Immunology
APR 13, 2020
Macrophages: An Origin Story
Macrophages are well-known defense cells of the immune system, responsible for utilizing the cellular breakdown process ...
APR 21, 2020
Health & Medicine
APR 21, 2020
How to Read COVID-19 News (Without Going Crazy)
  It can feel like COVID-19 news is consuming the country, and taking all the toilet paper and N95-masks with it. N ...
APR 27, 2020
Cell & Molecular Biology
APR 27, 2020
Cold Foods Don't Taste as Good, Even to Flies
The deliciousness of a food appeal is about a lot more than just taste.
MAY 10, 2020
Cell & Molecular Biology
MAY 10, 2020
RNA Structure Informs RNA Function
Proteins carry out many of an organism's critical functions, and they are coded for by genes. To make a protein from ...
JUN 16, 2020
Immunology
JUN 16, 2020
Stronger Skeletal Muscles May Reflect A Sturdy Immune System
Individuals struggling to recover from chronic infections and cancer usually experience reduced immune strength and weig ...
JUN 29, 2020
Genetics & Genomics
JUN 29, 2020
Why Two Similar Bacterial Toxins Cause Different Illnesses
The microbial pathogens of the world have shown us how powerful they can be, most recently proven by the current pandemi ...
Loading Comments...